Biomarkers and clinical trial design

Journal article

Peer reviewed

John Farley, Robert C. Bast and Michael J. Birrer

Gynecologic oncology, Vol.103(2), pp.3-5

11/01/2006

PMID: 17027069

Abstract

Biologic therapy

core laboratories for multi-institutional trials

future trial design Phase II and Phase III

Gynecologic

Malignancies

predictive markers

prognostic markers

Relevant biomarkers for the stratification of patients with ovarian cancer

surrogate markers

tissue banking needs

1 Record Views

Title: Biomarkers and clinical trial design
Creators: John Farley - Uniformed Services University of the Health Sciences
Robert C. Bast - The University of Texas MD Anderson Cancer Center
Michael J. Birrer - Cell and Cancer Biology Department, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
Publication Details: Gynecologic oncology, Vol.103(2), pp.3-5
Publisher: Elsevier Inc
Identifiers: 991005969000402656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article